VANCOUVER, British Columbia, Sept. 08, 2021 (GLOBE NEWSWIRE) —

Agra Ventures Ltd.


(“AGRA”


or


the


“Company”)


(CSE: AGRA)


(Frankfurt:


PU31)


(OTCPK:


AGFAF),

a growth-oriented and diversified company focused on the international cannabis industry, is pleased to announce that, further to its news release dated April 6, 2021, the Company has received notice from Organigram Holdings Inc. (“

Organigram

”) that the first of three Edibles & Infusions Corp. (“

EIC

”) earnout milestones (the “

First Milestone

”) was satisfied on August 13, 2021.

The First Milestone was satisfied upon the delivery of EIC-manufactured product to the Alberta recreational cannabis marketplace and triggered the aggregate release of $3,500,000 worth of Organigram common shares (the “

Earnout Shares

”) to the vendors of EIC. Specifically, AGRA is entitled to receive approximately 43 per cent of the Earnout Shares, or approximately $1,515,000 worth of the Earnout Shares, within 30 days of satisfying the First Milestone. The Earnout Shares are to be issued at the 5-day volume weighted average price of Organigram’s common shares as at the date of issuance.

Further, AGRA is eligible to receive approximately 43 per cent of an additional $9,500,000 of Organigram common shares, receivable upon the EIC business achieving certain earn-out milestones, as listed below:

• $7,000,000 to be received in common shares of Organigram upon the successful earning of $15,000,000 in net revenue during the 12 months ended Dec. 31, 2022; and
• $2,500,000 to be received in common shares of Organigram on the generation of $7,000,000 in adjusted earnings before interest, taxes, depreciation and amortization for the 12 months ended Dec. 31, 2022.

Management Commentary:

“The achievement of the First Milestone and related payment highlights the ‘Cannabis 2.0’ platform that was incubated by the Company. Also, it is a testament to the Company’s bench strength and to what AGRA hopes to achieve going forward. Management is squarely focused on AGRA’s three pillars of growth: Boundary Bay Cannabis in Delta, BC, Farmako GmbH in Germany, as well as the pursuit of an arrangement to enter the US cannabis market,” said Elise Coppens, CEO & Director of Agra Ventures.

ABOUT AGRA VENTURES

Agra Ventures Ltd. (“AGRA” or “the Company”) is a growth-oriented and diversified company focused on the international cannabis industry. The Company is dedicated to the cultivation, distribution and marketing of high-quality cannabis and cannabis-infused products worldwide. AGRA’s primary asset in Canada is Boundary Bay Cannabis located in Delta, BC, which is one of the largest cannabis greenhouse facilities focused on the cost-optimized cultivation of high-potency cannabis. Abroad, the Company’s wholly-owned subsidiary, Farmako GmbH, is focused on becoming Europe’s leading distributor of medical cannabis. Farmako currently has active product distribution operations in Germany and expects to commence active operations in the United Kingdom in 2021.

For more information about Agra Ventures, please visit

agraventures.com

and its profile page on SEDAR at


www.sedar.com

.

ON




BEHALF




OF




THE




BOARD




OF




DIRECTORS



Nick Kuzyk, Investor Relations

E:

[email protected]


T: (800) 783-6056

The


CSE


and


Information


Service


Provider


have


not


reviewed


and


does


not


accept


responsibility


for


the


accuracy


or


adequacy


of


this


release.

Forward-looking




Information




Cautionary




Statement

Except


for


statements


of


historic


fact


this


news


release


contains


certain


“forward-looking


information” within the meaning of applicable securities law. Forward-looking information is


frequently


characterized


by


words


such


as


“plan”


“expect”


“project”


“intend”


“believe”


“anticipate” “estimate” and other similar words or statements that certain events or conditions


“may” or “will” occur. Forward-looking statements are based on the opinions and estimates at


the date the statements are made and are subject to a variety of risks and uncertainties and other


factors that could cause actual events or results to differ materially from those anticipated in the


forward-looking statements including but not limited to delays or uncertainties with regulatory


approvals


including


that


of


the


CSE.


There


are


uncertainties


inherent


in


forward-looking


information including factors beyond the Company’s control. There are no assurances that the


remaining earn-out milestones will be achieved or that the


business


plans


for


Agra Ventures described


in


this


news


release


will


come


into


effect


on


the terms or time frame described herein. The Company undertakes no obligation to update


forward-looking information if circumstances or management’s estimates or opinions should


change except as required by law. The reader is cautioned not to place undue reliance on


forward-looking statements. Additional information identifying risks and uncertainties that could


affect financial results is contained in the Company’s filings with Canadian securities regulators


which


are


available


at



www.sedar.com.